In NASH mouse livers, western blot analysis revealed increased levels of p-AMPK (Figure 3B), suggesting that TXNIP protein accumulation in NASH is unlikely a result of impaired degradation downstream of APMK. The gene discussed is PRKAA2; the disease is metabolic dysfunction-associated steatohepatitis.